Total Payments
$13,861
2024 Payments
$2,043
Companies
55
Transactions
840
Medicare Patients
1,097
Medicare Billing
$109,998
Payment Breakdown by Category
Food & Beverage$13,521 (97.5%)
Education$189.97 (1.4%)
Consulting$150.00 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,521 | 817 | 97.5% |
| Education | $189.97 | 22 | 1.4% |
| Consulting Fee | $150.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,478 | 147 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,096 | 81 | $0 (2024) |
| MDD US Operations, LLC | $1,086 | 28 | $0 (2024) |
| ABBVIE INC. | $1,022 | 48 | $0 (2024) |
| Horizon Therapeutics plc | $823.70 | 30 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $800.67 | 48 | $0 (2024) |
| Genentech USA, Inc. | $684.06 | 39 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $594.29 | 33 | $0 (2024) |
| UCB, Inc. | $512.27 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $413.30 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,043 | 76 | MDD US Operations, LLC ($850.10) |
| 2023 | $3,760 | 216 | ABBVIE INC. ($458.58) |
| 2022 | $4,604 | 305 | Biogen, Inc. ($662.38) |
| 2021 | $3,453 | 243 | Biogen, Inc. ($390.76) |
All Payment Transactions
840 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: AMANTADINE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: AMANTADINE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: AMANTADINE | ||||||
| 08/16/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: AMANTADINE | ||||||
| 08/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: AMANTADINE | ||||||
| 07/02/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: AMANTADINE | ||||||
| 07/02/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: AMANTADINE | ||||||
| 06/28/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: AMANTADINE | ||||||
| 06/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: AMANTADINE | ||||||
| 05/07/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: AMANTADINE | ||||||
| 04/25/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Immunology | ||||||
| 04/24/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 04/21/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $39.98 | General |
| Category: Neurology | ||||||
| 04/05/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROLOGY | ||||||
| 04/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neurology | ||||||
| 04/05/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Neurology | ||||||
| 04/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neurology | ||||||
| 04/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: NEUROLOGY | ||||||
| 04/01/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 235 | 365 | $65,850 | $27,378 |
| 2022 | 5 | 274 | 400 | $85,545 | $31,095 |
| 2021 | 6 | 331 | 432 | $85,958 | $32,552 |
| 2020 | 5 | 257 | 375 | $45,630 | $18,973 |
Total Patients
1,097
Total Services
1,572
Medicare Billing
$109,998
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 255 | $38,250 | $18,901 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 34 | $6,800 | $3,639 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 60 | $6,000 | $3,012 | 50.2% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 16 | 16 | $14,800 | $1,827 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 263 | $39,450 | $19,290 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 55 | $11,000 | $5,953 | 54.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 19 | 19 | $17,575 | $2,258 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 41 | $4,100 | $1,802 | 44.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 21 | 22 | $13,420 | $1,791 | 13.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 141 | 207 | $31,050 | $16,009 | 51.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 62 | $12,400 | $7,202 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 114 | $10,910 | $5,445 | 49.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 16 | 16 | $14,800 | $1,802 | 12.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 16 | 16 | $9,760 | $1,319 | 13.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 17 | 17 | $7,038 | $776.16 | 11.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 158 | $23,700 | $9,608 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 167 | $15,030 | $6,379 | 42.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 23 | $4,600 | $2,023 | 44.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 12 | $1,175 | $553.68 | 47.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 15 | $1,125 | $409.97 | 36.4% |
About Patrick Rood, RPAC
Patrick Rood, RPAC is a Physician Assistant healthcare provider based in Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679681985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Rood, RPAC has received a total of $13,861 in payments from pharmaceutical and medical device companies, with $2,043 received in 2024. These payments were reported across 840 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($13,521).
As a Medicare-enrolled provider, Rood has provided services to 1,097 Medicare beneficiaries, totaling 1,572 services with total Medicare billing of $109,998. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Amherst, NY
- Active Since 08/27/2006
- Last Updated 10/25/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1679681985
Products in Payments
- KESIMPTA (Drug) $930.38
- Gocovri (Drug) $850.10
- UPLIZNA (Drug) $823.70
- BOTOX (Biological) $460.33
- TYSABRI (Biological) $454.94
- AVONEX (Biological) $410.04
- OCREVUS (Biological) $400.04
- NURTEC ODT (Drug) $395.73
- AUSTEDO (Drug) $377.68
- NUPLAZID (Drug) $356.33
- VUMERITY (Drug) $299.87
- RADICAVA (Drug) $298.59
- ONPATTRO (Drug) $290.04
- UBRELVY (Drug) $286.79
- RYTARY (Drug) $280.18
- Ocrevus (Biological) $247.14
- ULTOMIRIS (Biological) $245.99
- INGREZZA (Drug) $243.81
- AJOVY (Biological) $239.43
- NUEDEXTA (Drug) $239.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Amherst
Michael Asbach, Rpa-C, RPA-C
Physician Assistant — Payments: $658,572
Physician Assistant $658,572
Madeline Slisz, Pa-C, PA-C
Physician Assistant — Payments: $61,687
Physician Assistant $61,687
Rachel Allen, Rpa-C, RPA-C
Physician Assistant — Payments: $44,955
Physician Assistant $44,955
Lauren Flowers, Pa-C, PA-C
Physician Assistant — Payments: $34,288
Physician Assistant $34,288
Miss. Delaney Fragale, Pa-C, PA-C
Physician Assistant — Payments: $19,260
Physician Assistant $19,260
Megan Case, P.a, P.A
Physician Assistant — Payments: $15,988
Physician Assistant $15,988